Cor pulmonale

Reading File

Finding Sources

Searching PubMed

"cor pulmonale" AND management

Searching Images

cor pulmonale right heart failure ECG chest X-ray

This composite clinical figure illustrates the diagnosis and management of severe pulmonary hypertension and its complications. Panel A shows a transthoracic echocardiogram (TTE) in a patient with acute cor pulmonale. Labeled structures include a dilated right atrium and left ventricle, with an arrow highlighting the right ventricle free wall, demonstrating significant right heart strain. Panel B is a fluoroscopic image capturing an atrioseptostomy procedure. It depicts a transesophageal echo (TEE) probe positioned in the esophagus and a transeptal balloon inflated across the interatrial septum to create a right-to-left shunt. Panel C is an anteroposterior thoracic X-ray demonstrating bilateral pneumothorax with limited lung expansion. Visible medical devices include bilateral thoracic drainage tubes (chest tubes), an endotracheal tube, and ECG leads. The image set provides a comprehensive visual summary of hemodynamic monitoring, interventional rescue maneuvers for right ventricular failure, and subsequent pulmonary complications in a critical care setting.

**Imaging Modality:** Frontal Chest X-ray (CXR). **Anatomical Region:** Thoracic cavity, focusing on the cardiomediastinal silhouette and pulmonary vasculature. **Observed Pathology:** Findings are consistent with cor pulmonale secondary to severe pulmonary hypertension. **Characteristic Visual Features:** * **Cardiac Morphology:** Pronounced cardiomegaly with a "boot-shaped" appearance, characterized by an upturned apex and a prominent right heart border, indicating right ventricular and right atrial hypertrophy. * **Vascular Markings:** Significant prominence and dilation of the central pulmonary arteries (hilar engorgement). There is a marked discrepancy between the enlarged central vessels and the "pruning" or attenuation of peripheral pulmonary vascular markings. * **Mediastinum:** Expansion of the transverse cardiac diameter and a bulging pulmonary trunk segment along the left heart border. * **Lung Fields:** Increased lucency in the peripheral lung zones due to decreased perfusion (oligemia). **Diagnostic Cues:** The combination of central pulmonary artery dilation and right-sided heart enlargement without signs of left-sided failure (e.g., absence of Kerley B lines or pleural effusions) is highly suggestive of pulmonary arterial hypertension leading to chronic cor pulmonale.

This composite educational image includes a posteroanterior (PA) chest radiograph and a 12-lead electrocardiogram (ECG) demonstrating signs of congenital heart disease and hemodynamic stress. The chest X-ray reveals a moderately enlarged cardiac silhouette with an elongated, rounded apex and an excavated middle arch, suggesting ventricular dominance. A notable anatomical variation is the right-sided aortic arch. The pulmonary vasculature appears prominent, particularly in the hila and lower lung fields, which may indicate systemic-pulmonary collateral circulation. The accompanying ECG shows a sinus rhythm with markers of right-sided heart strain and cavity overload. Key findings include peaked P waves (P-pulmonale) in leads I, II, and left precordial leads, and a significant right-axis deviation of the QRS complex (+180º) with deep S waves from V3 through V6. T-wave inversions in the precordial leads further support right ventricular strain. This combination of findings is characteristic of complex cyanotic congenital heart disease, such as Tetralogy of Fallot or pulmonary atresia with a right-sided aortic arch.

Educational composite containing a posteroanterior chest X-ray and a 12-lead electrocardiogram (ECG) demonstrating complex congenital heart disease. The chest radiograph shows cardiomegaly with a prominent left ventricular contour and a bulging middle arch. A striking pulmonary vascular asymmetry is visible: the right lung shows increased hilar vascularity with peripheral tapering suggestive of pulmonary arterial hypertension, while the left lung exhibits significantly reduced vascular markings with thin, sparse vessels indicating pulmonary hypoperfusion. Below, the 12-lead ECG shows sinus rhythm with right axis deviation (+110 degrees) and signs of right cavity overload, including apiculate P waves (P-pulmonale) and a predominant S-wave pattern in leads V4-V6. Diffuse T-wave inversions are present in the precordial leads, reflecting generalized ventricular repolarization changes. This combination is clinically relevant for evaluating complex cyanotic heart defects, such as double outlet right ventricle with asymmetric pulmonary flow or pulmonary atresia.

Reading File

Loading Image

I now have excellent visual and textual content. Let me compile the comprehensive answer.

Cor Pulmonale

Definition: Right ventricular (RV) hypertrophy and dilation - frequently accompanied by right-sided heart failure - caused by pulmonary hypertension attributable to primary disorders of the lung parenchyma (e.g., COPD, interstitial fibrosis) or the pulmonary vasculature. RV enlargement caused by left ventricular failure or congenital heart disease is explicitly excluded from this definition.

Source: Robbins & Kumar Basic Pathology, p. 363

Pathogenesis Overview

Cor pulmonale pathogenesis diagram - Fuster and Hurst's The Heart, 15th Ed

The central mechanism follows this cascade:

Parenchymal destruction (emphysema, fibrosis) → loss of pulmonary vascular surface area
V/Q mismatch → hypoxemia ± hypercarbia
Hypoxic pulmonary vasoconstriction + vascular remodeling
Polycythemia (hypoxia-driven erythropoiesis) → increased blood viscosity → raised pulmonary vascular resistance
Elevated pulmonary artery pressure → RV pressure and volume overload
RV hypertrophy → eventually right heart failure

Endothelial dysfunction contributes by reducing vasodilatory mediators (prostacyclin, NO) and increasing vasoconstrictors (endothelin-1), further driving vascular remodeling. - Fuster and Hurst's The Heart, 15th Edition, p. 1773-1774

Etiology / Causes

Category	Examples
Obstructive lung disease	COPD (most common), asthma
Restrictive / parenchymal	Pulmonary fibrosis, sarcoidosis, pneumoconiosis
Vascular	Chronic thromboembolic disease, primary PAH
Chest wall / neuromuscular	Kyphoscoliosis, obesity hypoventilation, obstructive sleep apnea
Acute	Massive pulmonary embolism

Acute vs. Chronic

Feature	Acute Cor Pulmonale	Chronic Cor Pulmonale
Onset	Sudden (e.g., massive PE)	Slow and insidious
RV pathology	Dilation only; may even be normal size if sudden death	RV hypertrophy + dilation; RV wall may equal LV thickness
Cardiac output	Reduced	Normal or increased until late stages
Reversibility	Often reversible	Progressive; failure ensues late

Robbins & Kumar Basic Pathology, p. 363

Morphology (Gross Pathology)

Chronic cor pulmonale gross pathology - Robbins & Kumar Basic Pathology

(B) Chronic cor pulmonale: The right ventricle (shown on the left in the image) is markedly dilated and hypertrophied with a thickened free wall and hypertrophied trabeculae. The shape and volume of the left ventricle have been distorted by the enlarged RV. Compare with (A) systemic hypertensive heart disease showing concentric LV thickening.

In extreme cases the RV wall thickness can match or exceed that of the left ventricle (normal RV wall: ~3-5 mm). The pulmonary arteries show abnormal intimal thickening in the chronic form. - Robbins & Kumar Basic Pathology, p. 363

Pathophysiology of Edema

Peripheral edema in cor pulmonale is not simply due to pump failure (cardiac output is preserved until late). Multiple mechanisms operate:

Reduced renal plasma flow → impaired urinary sodium excretion
Hypercapnia → kidneys compensate for respiratory acidosis by retaining HCO3- and excreting H+, causing secondary sodium and water retention
Impaired oxygen tissue delivery → altered renal (and systemic) cellular metabolism → salt and water dysregulation
Intracellular acidosis from buffering chronic respiratory acidosis → augments organ dysfunction

Fuster and Hurst's The Heart, 15th Edition, p. 1775

Right Ventricular Response

Early/compensated: RV hypertrophies to handle increased afterload; cardiac output is maintained or elevated due to increased intravascular volume stretching myocardial fibers
"Pink puffer" (emphysema phenotype): Often has lower RV end-diastolic volumes due to lung hyperinflation reducing venous return
"Blue bloater" (chronic airways disease with hypoxemia/hypercapnia): More likely to develop overt pulmonary vascular disease and cor pulmonale
Late/decompensated: RV stiffness, ventriculo-arterial uncoupling, and RV dyssynchrony dominate; ventricular interdependence then impairs LV systolic and diastolic function as well

Fuster and Hurst's The Heart, 15th Edition, p. 1775-1776

Clinical Manifestations

Symptoms: Dyspnea on exertion (most common), fatigue, syncope or near-syncope on exertion, ankle swelling
Signs: Elevated JVP, right ventricular heave (parasternal lift), loud P2, tricuspid regurgitation murmur (pansystolic at left sternal border), hepatomegaly, peripheral pitting edema, cyanosis
Signs of the underlying lung disease dominate the clinical picture (barrel chest, wheeze, crepitations)

Investigations

Chest X-ray (CXR)

CXR showing cor pulmonale with central pulmonary artery dilation

Cardiomegaly with right-sided predominance ("boot-shaped" heart)
Prominent central pulmonary arteries (hilar engorgement)
Pruning of peripheral pulmonary vascular markings
Absence of pulmonary venous congestion (no Kerley B lines), distinguishing it from LV failure

ECG

P pulmonale - peaked P waves >2.5 mm in lead II (tall, narrow, due to right atrial enlargement)
Right axis deviation (QRS axis >+90°)
Right ventricular hypertrophy - dominant R in V1, deep S in V5-V6, R:S ratio >1 in V1
Right bundle branch block (complete or incomplete)
S1Q3T3 pattern in acute cor pulmonale (massive PE)
ST depression and T wave inversion in V1-V4 (RV strain)

Echocardiography

RV dilation and hypertrophy
Flattening/paradoxical motion of the interventricular septum ("D-shaped" LV in short axis)
Tricuspid regurgitation - allows estimation of RV systolic pressure (RVSP) via Bernoulli equation
Reduced RV ejection fraction; impaired RV function indices (TAPSE, S')
Right heart catheterization is the gold standard for measuring pulmonary artery pressure (mPAP ≥25 mmHg defines pulmonary hypertension)

Other

ABG: Hypoxemia (PaO2 low), hypercapnia in advanced disease
CBC: Polycythemia (secondary erythrocytosis)
PFTs: Confirm underlying obstructive or restrictive lung disease
CT PA / V/Q scan: Rule out thromboembolic disease
NT-proBNP / BNP: Elevated; useful for severity assessment and prognosis

Management

The cornerstone is treating the underlying lung disease to optimize respiratory mechanics and gas exchange. Specific approaches include:

1. Oxygen Therapy

Long-term oxygen therapy (LTOT) is the only intervention proven to improve survival in cor pulmonale due to COPD:

Indicated if resting PaO2 <55 mmHg on ambient air
Or PaO2 <59 mmHg if edema, polycythemia, or P pulmonale on ECG are also present
Target: maintain SpO2 ≥90%, SaO2 ≥90%
Goal: reverse hypoxic vasoconstriction and reduce pulmonary artery pressure

2. Treat the Underlying Cause

COPD: Bronchodilators, inhaled corticosteroids, pulmonary rehabilitation, smoking cessation
OSA: CPAP/BiPAP
Pulmonary fibrosis: Antifibrotics (pirfenidone, nintedanib)
Chronic PE: Anticoagulation; pulmonary thromboendarterectomy if eligible
Acute cor pulmonale (PE): Anticoagulation, thrombolysis, or embolectomy

3. Diuretics

Reduce fluid overload and peripheral edema
Use cautiously - aggressive diuresis can reduce RV preload and worsen output
Spironolactone may be added

4. Pulmonary Vasodilators

Role is limited and controversial in cor pulmonale due to lung disease (Group 3 PH)
Unlike Group 1 PAH, pulmonary vasodilators may worsen V/Q mismatch and systemic hypoxemia
Reserved for patients with disproportionate pulmonary hypertension (i.e., out of proportion to the degree of lung disease) - specialist decision
Options in PAH (Group 1): phosphodiesterase-5 inhibitors (sildenafil), endothelin receptor antagonists (bosentan), prostacyclins

5. Phlebotomy

For symptomatic polycythemia (hematocrit >65%)
Reduces blood viscosity and pulmonary vascular resistance

6. Cardiac Transplantation / Lung Transplantation

For end-stage disease refractory to medical therapy
Lung transplant can normalize RV function

Prognosis

Prognosis is closely tied to the severity of the underlying lung disease. Once overt right heart failure develops, 5-year mortality exceeds 50%. LTOT has been shown to significantly reduce mortality and reduce the rate of progression of pulmonary hypertension in COPD patients.

Key Distinguishing Points

Feature	Cor Pulmonale	LV Failure
Primary pathology	Lung disease	LV disease
Cardiac output	Normal/elevated (until late)	Reduced
Edema mechanism	Renal Na+ retention, hypercapnia	Reduced CO, RAAS activation
CXR	Dilated RV/RA, central PA dilation	Cardiomegaly, pulmonary venous congestion, Kerley B lines
S3 gallop	Right-sided (left sternal border, increases with inspiration)	Left-sided (apex)
Treatment target	Improve oxygenation and lung mechanics	Diuretics, ACEi, beta-blockers, SGLT2i

Sources:

Robbins & Kumar Basic Pathology, p. 363
Fuster and Hurst's The Heart, 15th Edition, pp. 1773-1778 (Chapter 59, Lewis J. Rubin)
Fishman's Pulmonary Diseases and Disorders, 2-Volume Set

This is a shared conversation. Sign in to Orris to start your own chat.